Tasly’s Modernized TCMs To Be Included In South African Medical Insurance
This article was originally published in PharmAsia News
Tianjin Tasly Group's seven modernized traditional Chinese medicines including Cardiotonic Pill have been confirmed as procurement products by the South African government for its medical insurance catalog. The China firm, in pursuing a globalization strategy, set up its South African branch in 2002 and has since seen its sales in the continent soar from $100,000 to an impressive $80 million in 2007. Cardiotonic Pill, Tasly's key product, has completed trademark registration in 34 countries and regions. The medicine is currently undergoing FDA and EMEA Phase ? and ? clinical trials. Tasly is using this opportunity to promote TCM, especially modernized traditional medicines, and gain entry into the mainstream market of developed countries. (Click here for more - Chinese language)
You may also be interested in...
In a bold move to expand into cancer treatment markets, Siemens Healthineers has agreed to a $16.4bn all-cash deal to acquire radiation therapy leader Varian.
Concern and skepticism about Russia's rapid vaccine roll-out. Meanwhile Japan is latest to reach reaches deal with Pfizer/BioNTech.
Sun’s Q1 earnings were dented by provisions related to the generic pricing investigation settlement with the US Department of Justice of arm Taro, and the impact of pandemic-related lockdowns. Some clinic-administered products bore the brunt of lock-downs in parts of the US, though market share was unaffected.